Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0005840 | ribosome | 5 | 11 |
GO:0020023 | kinetoplast | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 11 |
GO:0043226 | organelle | 2 | 11 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 11 |
GO:0043229 | intracellular organelle | 3 | 11 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:1990904 | ribonucleoprotein complex | 2 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0006412 | translation | 4 | 11 |
GO:0006518 | peptide metabolic process | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009058 | biosynthetic process | 2 | 11 |
GO:0009059 | macromolecule biosynthetic process | 4 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 11 |
GO:0043043 | peptide biosynthetic process | 5 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043603 | amide metabolic process | 3 | 11 |
GO:0043604 | amide biosynthetic process | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044249 | cellular biosynthetic process | 3 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 11 |
GO:1901576 | organic substance biosynthetic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003735 | structural constituent of ribosome | 2 | 11 |
GO:0005198 | structural molecule activity | 1 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 194 | 196 | PF00675 | 0.273 |
CLV_NRD_NRD_1 | 267 | 269 | PF00675 | 0.282 |
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.600 |
CLV_NRD_NRD_1 | 56 | 58 | PF00675 | 0.628 |
CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.692 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.461 |
CLV_PCSK_KEX2_1 | 196 | 198 | PF00082 | 0.272 |
CLV_PCSK_KEX2_1 | 267 | 269 | PF00082 | 0.282 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.600 |
CLV_PCSK_KEX2_1 | 56 | 58 | PF00082 | 0.462 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.596 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.692 |
CLV_PCSK_PC1ET2_1 | 167 | 169 | PF00082 | 0.461 |
CLV_PCSK_PC1ET2_1 | 196 | 198 | PF00082 | 0.282 |
CLV_PCSK_PC1ET2_1 | 75 | 77 | PF00082 | 0.611 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 212 | 216 | PF00082 | 0.327 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.668 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.638 |
DEG_APCC_DBOX_1 | 77 | 85 | PF00400 | 0.467 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.566 |
DEG_SPOP_SBC_1 | 23 | 27 | PF00917 | 0.683 |
DOC_CKS1_1 | 177 | 182 | PF01111 | 0.391 |
DOC_CYCLIN_RxL_1 | 208 | 216 | PF00134 | 0.586 |
DOC_MAPK_gen_1 | 195 | 201 | PF00069 | 0.482 |
DOC_MAPK_gen_1 | 227 | 236 | PF00069 | 0.419 |
DOC_PP1_RVXF_1 | 134 | 140 | PF00149 | 0.462 |
DOC_PP2B_PxIxI_1 | 242 | 248 | PF00149 | 0.562 |
DOC_SPAK_OSR1_1 | 197 | 201 | PF12202 | 0.496 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.741 |
DOC_USP7_UBL2_3 | 167 | 171 | PF12436 | 0.573 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.390 |
DOC_WW_Pin1_4 | 259 | 264 | PF00397 | 0.482 |
LIG_14-3-3_CanoR_1 | 96 | 105 | PF00244 | 0.598 |
LIG_deltaCOP1_diTrp_1 | 172 | 178 | PF00928 | 0.516 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.641 |
LIG_FHA_1 | 172 | 178 | PF00498 | 0.462 |
LIG_FHA_1 | 242 | 248 | PF00498 | 0.482 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.483 |
LIG_FHA_2 | 149 | 155 | PF00498 | 0.519 |
LIG_FHA_2 | 255 | 261 | PF00498 | 0.482 |
LIG_FHA_2 | 69 | 75 | PF00498 | 0.525 |
LIG_LIR_Apic_2 | 151 | 155 | PF02991 | 0.446 |
LIG_LIR_Gen_1 | 172 | 182 | PF02991 | 0.500 |
LIG_LIR_Nem_3 | 172 | 178 | PF02991 | 0.472 |
LIG_NRBOX | 80 | 86 | PF00104 | 0.498 |
LIG_SH2_NCK_1 | 152 | 156 | PF00017 | 0.465 |
LIG_SH2_SRC | 152 | 155 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.482 |
LIG_SH2_STAT5 | 282 | 285 | PF00017 | 0.482 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.533 |
LIG_SH3_1 | 110 | 116 | PF00018 | 0.637 |
LIG_SH3_1 | 127 | 133 | PF00018 | 0.400 |
LIG_SH3_3 | 110 | 116 | PF00018 | 0.551 |
LIG_SH3_3 | 127 | 133 | PF00018 | 0.418 |
LIG_SH3_3 | 174 | 180 | PF00018 | 0.425 |
LIG_SH3_3 | 196 | 202 | PF00018 | 0.482 |
LIG_UBA3_1 | 291 | 299 | PF00899 | 0.513 |
MOD_CDK_SPK_2 | 259 | 264 | PF00069 | 0.482 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.768 |
MOD_CK1_1 | 32 | 38 | PF00069 | 0.651 |
MOD_CK2_1 | 148 | 154 | PF00069 | 0.528 |
MOD_CK2_1 | 200 | 206 | PF00069 | 0.482 |
MOD_CK2_1 | 254 | 260 | PF00069 | 0.476 |
MOD_CK2_1 | 68 | 74 | PF00069 | 0.571 |
MOD_CK2_1 | 97 | 103 | PF00069 | 0.503 |
MOD_Cter_Amidation | 54 | 57 | PF01082 | 0.519 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.580 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.670 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.482 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.760 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.778 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.476 |
MOD_PK_1 | 44 | 50 | PF00069 | 0.452 |
MOD_PKA_1 | 4 | 10 | PF00069 | 0.466 |
MOD_PKA_1 | 96 | 102 | PF00069 | 0.607 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.480 |
MOD_PKA_2 | 96 | 102 | PF00069 | 0.607 |
MOD_PKB_1 | 187 | 195 | PF00069 | 0.496 |
MOD_PKB_1 | 57 | 65 | PF00069 | 0.438 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.527 |
MOD_Plk_1 | 68 | 74 | PF00069 | 0.571 |
MOD_Plk_2-3 | 249 | 255 | PF00069 | 0.492 |
MOD_Plk_4 | 59 | 65 | PF00069 | 0.480 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.386 |
MOD_ProDKin_1 | 259 | 265 | PF00069 | 0.482 |
MOD_SUMO_rev_2 | 229 | 239 | PF00179 | 0.482 |
MOD_SUMO_rev_2 | 249 | 257 | PF00179 | 0.496 |
TRG_DiLeu_BaLyEn_6 | 275 | 280 | PF01217 | 0.550 |
TRG_ER_diArg_1 | 195 | 198 | PF00400 | 0.473 |
TRG_ER_diArg_1 | 266 | 268 | PF00400 | 0.482 |
TRG_ER_diArg_1 | 3 | 5 | PF00400 | 0.606 |
TRG_ER_diArg_1 | 43 | 46 | PF00400 | 0.591 |
TRG_ER_diArg_1 | 56 | 59 | PF00400 | 0.500 |
TRG_Pf-PMV_PEXEL_1 | 127 | 132 | PF00026 | 0.489 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I854 | Leptomonas seymouri | 80% | 100% |
A0A1X0P6W5 | Trypanosomatidae | 70% | 100% |
A0A3S7WUX4 | Leishmania donovani | 94% | 100% |
A0A422P1R7 | Trypanosoma rangeli | 68% | 100% |
A4H9J1 | Leishmania braziliensis | 84% | 83% |
A4HXV4 | Leishmania infantum | 94% | 100% |
C9ZZU9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 73% | 100% |
E9ARL7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 99% |
V5DN42 | Trypanosoma cruzi | 67% | 100% |